339 related articles for article (PubMed ID: 25593345)
1. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
Shen J; Liu Z; Todd NW; Zhang H; Liao J; Yu L; Guarnera MA; Li R; Cai L; Zhan M; Jiang F
BMC Cancer; 2011 Aug; 11():374. PubMed ID: 21864403
[TBL] [Abstract][Full Text] [Related]
3. Dynamic enhancement patterns of solitary pulmonary nodules at multi-detector row CT and correlation with vascular endothelial growth factor and microvessel density.
Jiang NC; Han P; Zhou CK; Zheng JL; Shi HS; Xiao J
Ai Zheng; 2009 Feb; 28(2):164-9. PubMed ID: 19550130
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
[TBL] [Abstract][Full Text] [Related]
5. Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer.
Fahrmann JF; Grapov D; DeFelice BC; Taylor S; Kim K; Kelly K; Wikoff WR; Pass H; Rom WN; Fiehn O; Miyamoto S
Cancer Biomark; 2016 Mar; 16(4):609-17. PubMed ID: 27002763
[TBL] [Abstract][Full Text] [Related]
6. A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules.
Lin Y; Leng Q; Jiang Z; Guarnera MA; Zhou Y; Chen X; Wang H; Zhou W; Cai L; Fang H; Li J; Jin H; Wang L; Yi S; Lu W; Evers D; Fowle CB; Su Y; Jiang F
Int J Cancer; 2017 Sep; 141(6):1240-1248. PubMed ID: 28580707
[TBL] [Abstract][Full Text] [Related]
7. Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience.
Ohno Y; Hatabu H; Takenaka D; Adachi S; Kono M; Sugimura K
Radiology; 2002 Aug; 224(2):503-11. PubMed ID: 12147849
[TBL] [Abstract][Full Text] [Related]
8. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
[TBL] [Abstract][Full Text] [Related]
9. Solitary pulmonary nodules: comparison of multi-slice computed tomography perfusion study with vascular endothelial growth factor and microvessel density.
Bai RJ; Cheng XG; Qu H; Shen BZ; Han MJ; Wu ZH
Chin Med J (Engl); 2009 Mar; 122(5):541-7. PubMed ID: 19323905
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
Bar-Shalom R; Kagna O; Israel O; Guralnik L
Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
[TBL] [Abstract][Full Text] [Related]
11. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
[TBL] [Abstract][Full Text] [Related]
12. The value of macrophage inhibitory cytokine-1 level in differentiating benign from malignant solitary pulmonary nodules.
Xu CH; Xue JS; Zhang XW; Yu LK; Lin Y
Clin Respir J; 2018 Apr; 12(4):1473-1478. PubMed ID: 28834599
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules.
Gu T; Wen Z; Xu S; Hua H; Zhang Z; Wen T; Fu Z; Lv X
Afr Health Sci; 2014 Jun; 14(2):356-63. PubMed ID: 25320584
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Various Parameters of DWI in Distinguishing Solitary Pulmonary Nodules.
Guan HX; Pan YY; Wang YJ; Tang DZ; Zhou SC; Xia LM
Curr Med Sci; 2018 Oct; 38(5):920-924. PubMed ID: 30341530
[TBL] [Abstract][Full Text] [Related]
15. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
Lohrmann C; Weber WA
Zentralbl Chir; 2014 Feb; 139(1):108-13. PubMed ID: 24585199
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of malignant and benign pulmonary nodules with first-pass dual-input perfusion CT.
Yuan X; Zhang J; Quan C; Cao J; Ao G; Tian Y; Li H
Eur Radiol; 2013 Sep; 23(9):2469-74. PubMed ID: 23793548
[TBL] [Abstract][Full Text] [Related]
17. An update on sputum MicroRNAs in lung cancer diagnosis.
Sheervalilou R; Ansarin K; Fekri Aval S; Shirvaliloo S; Pilehvar-Soltanahmadi Y; Mohammadian M; Zarghami N
Diagn Cytopathol; 2016 May; 44(5):442-9. PubMed ID: 26865409
[TBL] [Abstract][Full Text] [Related]
18. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
[TBL] [Abstract][Full Text] [Related]
19. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
[TBL] [Abstract][Full Text] [Related]
20. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
Orlacchio A; Schillaci O; Antonelli L; D'Urso S; Sergiacomi G; Nicolì P; Simonetti G
Radiol Med; 2007 Mar; 112(2):157-73. PubMed ID: 17361379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
